Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT

Vir Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
74.2M 86.18M 1.58B 1.09B
Cost of Revenue
845K 2.77M 146.32M 65.86M
Gross Profit
73.36M 83.42M 1.43B 1.02B
Operating Income
-587.16M -684.3M 833.07M 276.89M
Interest Income
71.81M 86.99M 28.09M 439K
Pretax Income
-523.11M -628.19M 754.28M 549.8M
Net Income
-521.96M -615.06M 515.84M 528.58M
Selling & General & Admin
119.03M 174.05M 161.76M 160.79M
Research & Development
506.5M 589.67M 474.65M 448.01M
Other Expenses
34.99M n/a -35.33M -8.35M
Operating Expenses
660.52M 767.72M 601.09M 600.45M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
661.37M 770.49M 747.4M 666.32M
Income Tax Expense
-1.15M -13.08M 238.44M 21.22M
Shares Outstanding (Basic)
136.25M 134.13M 132.61M 129.88M
Shares Outstanding (Diluted)
136.25M 134.13M 134.81M 133.44M
EPS (Basic)
-3.83 -4.59 3.89 4.07
EPS (Diluted)
-3.83 -4.59 3.83 3.96
EBITDA
-537.61M -664.85M 833.07M 420.75M
EBIT
-552.17M -684.3M 754.28M 549.8M
Depreciation & Amortization
14.56M 19.45M 15.49M 11.98M